Authors: Hylek, EM

Citation: Em. Hylek, Oral anticoagulants - Pharmacologic issues for use in the elderly, CLIN GERIAT, 17(1), 2001, pp. 1

Authors: Go, AS Hylek, EM Phillips, KA Chang, YC Henault, LE Selby, JV Singer, DE

Citation: As. Go et al., Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, J AM MED A, 285(18), 2001, pp. 2370-2375

Authors: Hylek, EM Regan, S Go, AS Hughes, RA Singer, DE Skates, SJ

Citation: Em. Hylek et al., Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin, ANN INT MED, 135(6), 2001, pp. 393-400

Authors: Rosand, J Hylek, EM O'Donnell, HC Greenberg, SM

Citation: J. Rosand et al., Warfarin-associated hemorrhage and cerebral amyloid angiopathy - A geneticand pathologic study, NEUROLOGY, 55(7), 2000, pp. 947-951

Authors: Go, AS Hylek, EM Phillips, KA Borowsky, LH Henault, LE Chang, YC Selby, JV Singer, DE

Citation: As. Go et al., Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation - The anticoagulation and risk factors in atrial fibrillation (ATRIA) study, CIRCULATION, 102(1), 2000, pp. 11-13

Authors: Go, AS Hylek, EM Borowsky, LH Phillips, KA Selby, JV Singer, DE

Citation: As. Go et al., Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study, ANN INT MED, 131(12), 1999, pp. 927